Pasireotide Subcutaneous and QT prolongation
Result of checking the interaction of drug Pasireotide Subcutaneous and disease QT prolongation for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of pasireotide is associated with QT prolongation. Pasireotide should be used with caution in patients who are at significant risk of developing QT prolongation. It is recommended to correct levels of hypokalemia and hypomagnesemia prior to starting therapy with this agent. Assess ECG at the beginning of therapy and monitor during therapy. Care should be taken in predisposed patients.
Generic Name: pasireotide
Brand Name: Signifor, Signifor LAR
Synonyms: Pasireotide
Pasireotide Subcutaneous - Wydłużenie odstępu QT 
Pasireotide Subcutaneous - Prolongamento QT 
Pasireotide Subcutaneous - Pemanjangan QT 
Pasireotide Subcutaneous - Perpanjangan QT 
Pasireotide Subcutaneous - Prolungamento dell'intervallo QT 
Pasireotide Subcutaneous - Allongement de l'intervalle QT 
Pasireotide Subcutaneous - QT-Verlängerung 
Pasireotide Subcutaneous - Prolongación del intervalo QT 
Pasireotide Subcutaneous - удлинение интервала QT 
Pasireotide Subcutaneous - QT uzaması 
Pasireotide Subcutaneous - إطالة كيو تي 
Pasireotide Subcutaneous - QT延长